Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.
about
The impact of antiviral therapy for hepatitis C on the quality of life: a perspective.Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.
P2860
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@en
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@nl
type
label
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@en
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@nl
prefLabel
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@en
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@nl
P2093
P2860
P1476
Assessing the Effect of Potent ...... Early Stages of Liver Disease.
@en
P2093
Andrew J Leidner
Harrell W Chesson
Philip R Spradling
Scott D Holmberg
P2860
P2888
P356
10.1007/S40258-016-0261-2
P577
2016-08-01T00:00:00Z